Mapmygenome Inc, headquartered in India, is an international provider of high quality products for research and diagnostics of infectious disease. Their portolio includes an innovative and extremely effective product line for detection of Mycobacterium tuberculosis,called Spoligotyping. It is a PCR based method to simultaneously detect and type Mycobacterium tuberculosis complex. Spoligotpying represents alternative of Southern blotting used by many research institutions, clinics and hospitals, that need to receive fast and reliable results.